A novel compound Myrtocomuloacetalone 1 (MCA-1) exhibiting potent anti-inflammatory properties by inhibiting production of reactive oxygen species, including nitric oxide, superoxide, and hydrogen peroxide that effectively suppresses proliferation of T-cells and also reduces intracellular oxidative stress and inhibits NF kappa B activation.